RecruitingNot Applicable

Contraceptive Efficacy Study of Ovaprene

United States656 participantsStarted 2023-12-19

Plain-language summary

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓-At least 18 years old, not known to be subfertile or infertile

Exclusion criteria

✕-systemic use in the last 2 weeks prior to screening or anticipated use during the study of antibiotics (other than those used to treat urinary tract infection (UTI), candidiasis, or bacterial vaginosis(BV) diagnosed at Visit 1) or antivirals;

What they're measuring

Determination of pregnancy rate

Timeframe: 12 months

Trial details

NCT IDNCT06127199

SponsorDaré Bioscience, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-04

Contact for this trial

Christine Mauck, MD

www.ovaprenestudy.com cmauck@darebioscience.com

View on ClinicalTrials.gov More Contraception trials